SECOND SIGHT MED PRODS INC's ticker is EYESXXXX and the CUSIP is 81362J100. A total of 60 filers reported holding SECOND SIGHT MED PRODS INC in Q1 2016. The put-call ratio across all filers is 1.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $98,000 | +1.0% | 50,804 | 0.0% | 0.02% | +26.3% |
| Q4 2017 | $97,000 | +59.0% | 50,804 | 0.0% | 0.02% | +90.0% |
| Q3 2017 | $61,000 | -4.7% | 50,804 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $64,000 | +4.9% | 50,804 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $61,000 | -39.0% | 50,804 | 0.0% | 0.01% | -41.2% |
| Q4 2016 | $100,000 | -44.1% | 50,804 | 0.0% | 0.02% | -39.3% |
| Q3 2016 | $179,000 | -1.6% | 50,804 | 0.0% | 0.03% | -33.3% |
| Q2 2016 | $182,000 | -25.7% | 50,804 | 0.0% | 0.04% | -34.4% |
| Q1 2016 | $245,000 | -79.5% | 50,804 | -75.0% | 0.06% | -69.2% |
| Q4 2015 | $1,198,000 | -50.3% | 203,438 | -50.0% | 0.21% | -15.8% |
| Q3 2015 | $2,412,000 | -15.6% | 406,876 | +93.8% | 0.25% | -28.8% |
| Q2 2015 | $2,859,000 | +6.2% | 210,000 | 0.0% | 0.35% | +1.5% |
| Q1 2015 | $2,692,000 | -39.2% | 210,000 | -51.3% | 0.34% | -41.1% |
| Q4 2014 | $4,428,000 | – | 431,582 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,492,975 | $5,616,219,000 | 4.42% |
| CARL DOMINO INC | 112,719 | $142,000 | 0.16% |
| VAN DEN BERG MANAGEMENT I, INC | 243,679 | $307,000 | 0.04% |
| ELEMENT CAPITAL MANAGEMENT LLC | 112,735 | $142,000 | 0.03% |
| Psagot Value Holdings Ltd. | 195,999 | $247,000 | 0.01% |
| ORACLE INVESTMENT MANAGEMENT INC | 50,804 | $64,000 | 0.01% |
| B. Riley Wealth Advisors, Inc. | 28,927 | $37,000 | 0.01% |
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 18,894 | $24,000 | 0.01% |
| WEALTHSOURCE PARTNERS, LLC | 10,000 | $13,000 | 0.00% |
| LMR Partners LLP | 50,168 | $63,000 | 0.00% |